VeriMom¿Es dihydroquercetin pentacaprylate seguro durante el embarazo?
No harmonised CLP reproductive classification or SCCS/CIR safety assessment was found for dihydroquercetin pentacaprylate. Peer‑reviewed animal and in vitro studies on the parent compound (taxifolin/dihydroquercetin) report no evidence of intrinsic reproductive/teratogenic hazard and in some cases show protective effects against chemical‑induced reproductive damage, so there is no credible evidence to up‑rank hazard. (See CosIng listing for the INCI and PubMed studies on taxifolin.) Sources: EU Official Journal (Cosmetic ingredient listing), PubMed studies on taxifolin reproductive effects.
Related ingredients
Frequently asked questions
- ¿Es dihydroquercetin pentacaprylate seguro durante el embarazo?
- No harmonised CLP reproductive classification or SCCS/CIR safety assessment was found for dihydroquercetin pentacaprylate. Peer‑reviewed animal and in vitro studies on the parent compound (taxifolin/dihydroquercetin) report no evidence of intrinsic reproductive/teratogenic hazard and in some cases show protective effects against chemical‑induced reproductive damage, so there is no credible evidence to up‑rank hazard. (See CosIng listing for the INCI and PubMed studies on taxifolin.) Sources: EU Official Journal (Cosmetic ingredient listing), PubMed studies on taxifolin reproductive effects.
- ¿Es dihydroquercetin pentacaprylate seguro durante la lactancia?
- No data specific to lactation or breastmilk transfer for the pentacaprylate or parent dihydroquercetin were located. Because there is no evidence of reproductive toxicity or endocrine disruption for the parent and no harmonised flags, hazard and mechanism remain 0. Exposure from topical cosmetic use was not shown to be high. No SCCS/CIR contraindication found.
- ¿Es dihydroquercetin pentacaprylate seguro para la piel del bebé?
- Hazard/mechanism: no infant‑specific reproductive or developmental hazard data were found for this derivative or for taxifolin; peer‑reviewed work shows taxifolin is not a reproductive teratogen and can be protective in rodent models, so h/m remain 0. Exposure: no dermal absorption data for the pentacaprylate were located. Per instructions, when adult topical absorption evidence is lacking but the ingredient is not absolutely non‑absorbable, increase baby exposure by +1 due to higher baby surface‑area:body‑weight and immature barrier.
- ¿Cómo puntúa VeriMom a dihydroquercetin pentacaprylate?
- VeriMom puntúa dihydroquercetin pentacaprylate en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a dihydroquercetin pentacaprylate en el embarazo?
- Consulta nuestra lista de alternativas seguras a dihydroquercetin pentacaprylate según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.